BiotechTube
Home/Vesselon/Clay Larsen
CL

Clay Larsen

CEO and Co-founder

Vesselon

Therapeutic Areas

Oncology

Vesselon Pipeline

DrugIndicationPhase
SonoPembro™Multiple Solid Tumors (to improve Keytruda ORR)Pre-clinical
SonoLeukin™Multiple Solid TumorsPre-clinical
SonoVastin™Not Specified (bevacizumab-based)Pre-clinical